The difficult Way to HIV Vaccine
Wednesday, September 16, 2009 - 10:21
in Health & Medicine
T cells are key players in the immune response to HIV, which are able to delete infected cells. This capacity is used for vaccine development against HIV. `To date however, success of this strategy remains elusive. Our understanding of T cell efficacy is still limited, and we need to identify precise T cell correlates of protection that could guide rationale vaccine design`, says Victor Appay, Group leader HIV Pathogenesis and Immunosenescence, Hopital Pitie-Salpetriere, Paris, at the 2nd European Congress of Immunology ECI 2009 in Berlin.